A pain treatment with bite


start-up-idea-spiderSpider venom could soon be used to relieve chronic pain conditions.


Institute for Molecular Bioscience (IMB) researchers have partnered with Johnson & Johnson to develop components of spider venom that may be effective as a treatment for pain.


Funding will support a 12-month project to characterise novel spider venom peptides that were discovered in a proprietary IMB testing procedure to inhibit a human ion channel (ion channels regulate ion flows across cell membranes), critical for sensing pain.


The long-term goal is to develop these peptides for the therapeutic treatment of chronic pain.


UniQuest managing director David Henderson says the partnership will accelerate the process of seeking a solution to chronic pain, a health problem estimated to affect 1.5 billion people.


“Discoveries like this pass through many developmental stages before they become market-ready therapeutic products,” Henderson says.


The use of spider venom as a potential treatment for pain could represent a major opportunity for the right entrepreneur, so why not do some research of your own?

Previous articleDo investors keep an eye on ideas they’ve rejected?
Next articleFive key tax busting strategies